0001213900-20-037981.txt : 20201118
0001213900-20-037981.hdr.sgml : 20201118
20201118162523
ACCESSION NUMBER: 0001213900-20-037981
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201106
FILED AS OF DATE: 20201118
DATE AS OF CHANGE: 20201118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Feldmann Marc
CENTRAL INDEX KEY: 0001832327
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 201325418
MAIL ADDRESS:
STREET 1: 5 DURHAM TERRACE
CITY: LONDON
STATE: X0
ZIP: W25PB
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 WEST 56TH STREET SUITE 5901
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-319-5555
MAIL ADDRESS:
STREET 1: 150 WEST 56TH STREET SUITE 5901
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
3
1
ownership.xml
X0206
3
2020-11-06
0
0001690080
180 Life Sciences Corp.
ATNF
0001832327
Feldmann Marc
830 MENLO AVENUE, SUITE 100
MENLO PARK
CA
94025
1
0
1
0
Common Stock
2596848
D
/s/ Sir Marc Feldmann, Ph.D.
2020-11-18